BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 28356429)

  • 21. Postprandial distribution of apolipoproteins C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: comparison of meals containing corn oil and medium-chain triglyceride oil.
    Barr SI; Kottke BA; Mao SJ
    Metabolism; 1985 Nov; 34(11):983-92. PubMed ID: 4058312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA; Stentz F; Gettys T; Smith SR
    Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity.
    Chan DC; Watts GF; Barrett PH; Mamo JC; Redgrave TG
    Clin Chem; 2002 Feb; 48(2):278-83. PubMed ID: 11805008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preferential cholesteryl ester acceptors among triglyceride-rich lipoproteins during alimentary lipemia in normolipidemic subjects.
    Lassel TS; Guérin M; Auboiron S; Chapman MJ; Guy-Grand B
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):65-74. PubMed ID: 9445258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial plasma lipoprotein changes in human subjects of different ages.
    Cohn JS; McNamara JR; Cohn SD; Ordovas JM; Schaefer EJ
    J Lipid Res; 1988 Apr; 29(4):469-79. PubMed ID: 3392464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of three fatty meals in healthy normolipidaemic men: high post-prandial retinyl ester response to soybean oil.
    Mero N; Syvänne M; Rosseneu M; Labeur C; Hilden H; Taskinen MR
    Eur J Clin Invest; 1998 May; 28(5):407-15. PubMed ID: 9650015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postprandial triglyceride response in visceral obesity in men.
    Couillard C; Bergeron N; Prud'homme D; Bergeron J; Tremblay A; Bouchard C; Mauriège P; Després JP
    Diabetes; 1998 Jun; 47(6):953-60. PubMed ID: 9604874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ApoC-III ASO promotes tissue LPL activity in the absence of apoE-mediated TRL clearance.
    Ramms B; Patel S; Nora C; Pessentheiner AR; Chang MW; Green CR; Golden GJ; Secrest P; Krauss RM; Metallo CM; Benner C; Alexander VJ; Witztum JL; Tsimikas S; Esko JD; Gordts PLSM
    J Lipid Res; 2019 Aug; 60(8):1379-1395. PubMed ID: 31092690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype.
    Zheng C; Khoo C; Furtado J; Sacks FM
    Circulation; 2010 Apr; 121(15):1722-34. PubMed ID: 20368524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
    Chan DC; Watts GF; Nguyen MN; Barrett PH
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):590-6. PubMed ID: 16410456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triglyceride-rich lipoprotein metabolism in women: roles of apoC-II and apoC-III.
    Ooi EM; Chan DC; Hodson L; Adiels M; Boren J; Karpe F; Fielding BA; Watts GF; Barrett PH
    Eur J Clin Invest; 2016 Aug; 46(8):730-6. PubMed ID: 27378472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state.
    Marcoux C; Hopkins PN; Wang T; Leary ET; Nakajima K; Davignon J; Cohn JS
    J Lipid Res; 2000 Sep; 41(9):1428-36. PubMed ID: 10974050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.
    Fredenrich A; Giroux LM; Tremblay M; Krimbou L; Davignon J; Cohn JS
    J Lipid Res; 1997 Jul; 38(7):1421-32. PubMed ID: 9254067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Evolocumab on the Postprandial Kinetics of Apo (Apolipoprotein) B100- and B48-Containing Lipoproteins in Subjects With Type 2 Diabetes.
    Taskinen MR; Björnson E; Kahri J; Söderlund S; Matikainen N; Porthan K; Ainola M; Hakkarainen A; Lundbom N; Fermanelli V; Fuchs J; Thorsell A; Kronenberg F; Andersson L; Adiels M; Packard CJ; Borén J
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):962-975. PubMed ID: 33356392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma kinetics of apoC-III and apoE in normolipidemic and hypertriglyceridemic subjects.
    Batal R; Tremblay M; Barrett PH; Jacques H; Fredenrich A; Mamer O; Davignon J; Cohn JS
    J Lipid Res; 2000 May; 41(5):706-18. PubMed ID: 10787431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A reduction of CETP activity, not an increase, is associated with modestly impaired postprandial lipemia and increased HDL-cholesterol in adult asymptomatic women.
    Parra ES; Urban A; Panzoldo NB; Nakamura RT; Oliveira R; de Faria EC
    Lipids Health Dis; 2011 May; 10():87. PubMed ID: 21609439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postprandial exchange of apolipoprotein C-III between plasma lipoproteins.
    Barr SI; Kottke BA; Mao SJ
    Am J Clin Nutr; 1981 Feb; 34(2):191-8. PubMed ID: 7211723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
    Khetarpal SA; Zeng X; Millar JS; Vitali C; Somasundara AVH; Zanoni P; Landro JA; Barucci N; Zavadoski WJ; Sun Z; de Haard H; Toth IV; Peloso GM; Natarajan P; Cuchel M; Lund-Katz S; Phillips MC; Tall AR; Kathiresan S; DaSilva-Jardine P; Yates NA; Rader DJ
    Nat Med; 2017 Sep; 23(9):1086-1094. PubMed ID: 28825717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome.
    Chan DC; Watts GF; Ng TW; Yamashita S; Barrett PH
    Eur J Clin Invest; 2008 Oct; 38(10):743-51. PubMed ID: 18837799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.